India, Sept. 21 -- image credit- freepik

Delhi-based Akums Drugs & Pharmaceuticals has announced the development of a DCGI-approved Clarithromycin + Vonoprazan + Amoxicillin Combikit for the treatment of Helicobacter pylori (H. pylori) infection in adults.

The development is part of the company's ongoing work in pharmaceutical formulation and reflects the growing focus within healthcare on treatment approaches that consider both therapeutic requirements and the practical aspects of completing a prescribed regimen.

H. pylori infection is associated with chronic gastritis and peptic ulcer disease and is recognised as an important risk factor for gastric cancer. Effective eradication of the infection is therefore an important therapeutic ...